Ryan Reavis Agrees To Plead Guilty To Charge Connected To Mac Miller's Overdose Death

LOS ANGELES (AP/KDKA) — An Arizona man accused of supplying the dealer who sold Mac Miller the drugs that killed the rapper has agreed to plead guilty to a federal charge, prosecutors said Wednesday.

Ryan Michael Reavis, 38, will admit to a single count of distribution of fentanyl, the U.S. Attorney's Office in Los Angeles said in a statement.

Photo Credit: Lake Havasu City Police Dept

Reavis knowingly supplied counterfeit oxycodone pills containing fentanyl to co-defendant Cameron James Pettit, 30, of Los Angeles, according to a plea agreement. Pettit sold the pills and other drugs to Miller, who two days later suffered a fatal overdose, according to prosecutors.

Another co-defendant, Stephen Andrew Walter, 48, of Los Angeles, agreed last month to plead guilty to one count of distribution of fentanyl. Prosecutors said Reavis supplied the pills to Pettit at the direction of Walter. Reavis and Walter are each expected to enter their pleas in the coming weeks.

The case against Pettit is pending.

Reavis, formerly of West Los Angeles, moved to Lake Havasu, Arizona, in 2019.

Miller's assistant found the rapper unresponsive in his Los Angeles home on Sept. 7, 2018, and he was declared dead soon after.

Miller, a Pittsburgh native whose real name was Malcolm James Myers McCormick, was a beloved and respected figure among hip-hop fans. "Circles," his sixth and final studio album, was released posthumously in 2020.

Miller's legacy lives on at Blue Slide Park in Frick Park. "Blue Slide Park" was the name of Miller's first album, and the park has become the site of memorials celebrating his life.

(TM and © Copyright 2020 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.